Share Email Print

Proceedings Paper

Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power
Author(s): H. Tadayyon; Lakshmanan Sannachi; G. J. Czarnota
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Conventional assessment of tumor response to anti-cancer therapy is based on measurements of tumor size (RECIST criteria). However, these measurements are typically a late indicator of tumor response (detectable after several weeks to a few months). There is currently no method to assess tumor response early in the course of therapy. In this study, quantitative ultrasound (QUS) methods were used to characterize the frequency-dependent attenuation and backscatter properties of treatment responding and non-responding tumors in breast cancer patients receiving neoadjuvant chemotherapy. In addition, we assessed the effects of attenuation correction of the power spectrum on the ability to differentiate between responding and non-responding tumors during the course of treatment.

Paper Details

Date Published: 20 March 2014
PDF: 8 pages
Proc. SPIE 9040, Medical Imaging 2014: Ultrasonic Imaging and Tomography, 904009 (20 March 2014); doi: 10.1117/12.2043075
Show Author Affiliations
H. Tadayyon, Sunnybrook Health Science Ctr. (Canada)
Univ. of Toronto (Canada)
Lakshmanan Sannachi, Sunnybrook Health Sciences Ctr. (Canada)
Univ. of Toronto (Canada)
G. J. Czarnota, Sunnybrook Health Science Ctr. (Canada)
Univ. of Toronto (Canada)

Published in SPIE Proceedings Vol. 9040:
Medical Imaging 2014: Ultrasonic Imaging and Tomography
Johan G. Bosch; Marvin M. Doyley, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?